Following on from the success of our 2010 and 2011 events, Professor Gary Lye is Chairing the third meeting in the series "Miniaturisation -Micro Scale Bioprocess Development". Miniaturisation and automation of bioprocess development continues to be a rapidly expanding area of interest since the technologies promise to reduce biopharmaceutical development time and cost. This meeting aims to highlight recent technologies used in high throughput bioprocess development, from clone selection through to analysis of final product and formulation. A series of expert speakers will describe the development and use of current miniaturisation technologies together with the  technical and regulatory hurdles that must be overcome to facilitate wider industrial uptake.